IT 139 companion diagnostic - Intezyne
Latest Information Update: 14 Jan 2015
At a glance
- Originator Intezyne
- Class Diagnostic agents
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 14 Jan 2015 Preclinical trials in Solid tumours (Diagnosis) in USA and European Union (unspecified route)